{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:24Z","timestamp":1790790324052,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cld.2016.12.004","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T08:33:44Z","timestamp":1487838824000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Extended Criteria Donors in Liver Transplantation"],"prefix":"10.1016","volume":"21","author":[{"given":"Irine","family":"Vodkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2016.12.004_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.13668","article-title":"Liver","volume":"16","author":"Kim","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib2","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/lt.21668","article-title":"Report of the Paris consensus meeting on expanded criteria donors in liver transplantation","volume":"14","author":"Durand","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000052829","article-title":"The aging liver: structural and functional changes and their consequences for drug treatment in old age","volume":"48","author":"Zeeh","year":"2002","journal-title":"Gerontology"},{"key":"10.1016\/j.cld.2016.12.004_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00007890-200208270-00015","article-title":"Influence of marginal donors on liver preservation injury","volume":"74","author":"Briceno","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","article-title":"Age-related changes in liver structure and function: implications for disease","volume":"40","author":"Schmucker","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.cld.2016.12.004_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/jsre.2002.6462","article-title":"Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry","volume":"106","author":"Wakabayashi","year":"2002","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.cld.2016.12.004_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00007890-199604150-00013","article-title":"Graft function and outcome of older (> or\u00a0= 60 years) donor livers","volume":"61","author":"Washburn","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007890-199908270-00021","article-title":"Use of octogenarian livers safely expands the donor pool","volume":"68","author":"Jimenez Romero","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00007890-199304000-00024","article-title":"Risk factors for primary dysfunction after liver transplantation\u2013a multivariate analysis","volume":"55","author":"Ploeg","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib11","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/lt.21946","article-title":"Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors","volume":"15","author":"Stewart","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-6143.2001.010112.x","article-title":"A\u00a0revised consideration on the use of very aged donors for liver transplantation","volume":"1","author":"Grazi","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1399-0012.2009.01135.x","article-title":"Outcome of liver transplantation using donors older than 60 years of age","volume":"24","author":"Serrano","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/lt.24401","article-title":"Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors","volume":"22","author":"Ghinolfi","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jamcollsurg.2015.01.061","article-title":"Donor age-based analysis of liver transplantation outcomes: short- and long-term outcomes are similar regardless of donor age","volume":"221","author":"Chapman","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.transproceed.2006.12.002","article-title":"Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis","volume":"39","author":"Schemmer","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2016.12.004_bib17","first-page":"196","article-title":"Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit?","volume":"8","author":"Singhal","year":"2010","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/00007890-200106270-00011","article-title":"The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival","volume":"71","author":"Busquets","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archsurg.140.3.273","article-title":"Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation","volume":"140","author":"Moore","year":"2005","journal-title":"Arch Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1600-6143.2005.00741.x","article-title":"Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis","volume":"5","author":"Lake","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1600-6143.2004.00472.x","article-title":"Liver transplantation from donors aged 80 years and over: pushing the limit","volume":"4","author":"Nardo","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1432-2277.2012.01474.x","article-title":"How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?","volume":"25","author":"Uemura","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.cld.2016.12.004_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.51.2.248","article-title":"Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C","volume":"51","author":"Wali","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.12.004_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.tp.0000188619.30677.84","article-title":"Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus","volume":"81","author":"Mutimer","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib27","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/ajt.12843","article-title":"Use of octogenarian donors for liver transplantation: a survival analysis","volume":"14","author":"Ghinolfi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/lt.21433","article-title":"Improving the outcome of liver transplantation with very old donors with updated selection and management criteria","volume":"14","author":"Cescon","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1399-0012.2010.01222.x","article-title":"Liver transplantation using elderly donors: a risk factor analysis","volume":"25","author":"Kim","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib30","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1016\/j.transproceed.2005.10.040","article-title":"Donors older than 70 years in liver transplantation","volume":"37","author":"Gastaca","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2016.12.004_bib31","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00268-013-2085-7","article-title":"Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years","volume":"37","author":"Jimenez-Romero","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib32","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.004_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2016.12.004_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2016.12.004_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jss.2007.12.784","article-title":"Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury","volume":"152","author":"Berthiaume","year":"2009","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.cld.2016.12.004_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00007890-199901270-00002","article-title":"The mechanism of injury in a steatotic liver graft during cold preservation","volume":"67","author":"Fukumori","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib37","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/lt.23905","article-title":"Elevated sensitivity of macrosteatotic hepatocytes to hypoxia\/reoxygenation stress is reversed by a novel defatting protocol","volume":"20","author":"Nativ","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2005.07.032","article-title":"Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis","volume":"44","author":"Selzner","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib39","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.004_bib40","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1440-1746.2011.06844.x","article-title":"Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index","volume":"27","author":"de Graaf","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/SLA.0b013e31815c2a3f","article-title":"Use of severely steatotic grafts in liver transplantation: a matched case-control study","volume":"246","author":"McCormack","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib42","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/lt.22085","article-title":"The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment","volume":"16","author":"Spitzer","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/lt.24335","article-title":"Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors","volume":"22","author":"Wong","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib44","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/ctr.12211","article-title":"Safe use of highly steatotic livers by utilizing a donor\/recipient clinical algorithm","volume":"27","author":"Chavin","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/SLA.0b013e318272dea2","article-title":"The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score","volume":"256","author":"Dutkowski","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib46","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/TP.0b013e31828d1588","article-title":"Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy","volume":"95","author":"Ahn","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-0012.2009.00987.x","article-title":"Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy?","volume":"23","author":"Cucchetti","year":"2009","journal-title":"Clinical Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2442061177","article-title":"Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index","volume":"244","author":"Lee","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2016.12.004_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/lt.23615","article-title":"Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers","volume":"19","author":"Yersiz","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/lt.21419","article-title":"Utility of liver allograft biopsy obtained at procurement","volume":"14","author":"Lo","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/lt.23406","article-title":"Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation","volume":"18","author":"Broomhead","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.TP.0000437178.48174.db","article-title":"Donation after circulatory death: current practices, ongoing challenges, and potential improvements","volume":"97","author":"Morrissey","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-0012.2009.00968.x","article-title":"Long-term outcomes of donation after cardiac death liver allografts from a single center","volume":"23","author":"Nguyen","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.surg.2009.06.052","article-title":"The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story","volume":"146","author":"Skaro","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.cld.2016.12.004_bib55","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2011.03899.x","article-title":"Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN\/UNOS data","volume":"12","author":"Uemura","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SLA.0b013e318204e658","article-title":"Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis","volume":"253","author":"Jay","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1600-6143.2009.02560.x","article-title":"Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center","volume":"9","author":"de Vera","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/lt.21361","article-title":"Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors","volume":"14","author":"Chan","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/lt.23418","article-title":"Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: recognizing who can benefit","volume":"18","author":"Jay","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib60","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1600-6143.2010.03293.x","article-title":"Donation after cardiac death liver transplantation: predictors of outcome","volume":"10","author":"Mathur","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib61","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archsurg.2011.240","article-title":"Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib62","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/TP.0b013e31822a79d2","article-title":"Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts","volume":"92","author":"Hernandez-Alejandro","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib63","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/lt.22168","article-title":"Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts","volume":"16","author":"Tao","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/lt.22258","article-title":"Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus","volume":"17","author":"Taner","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib65","doi-asserted-by":"crossref","first-page":"154","DOI":"10.6002\/ect.2012.0173","article-title":"Liver transplant using donors after cardiac death: a single-center approach providing outcomes comparable to donation after brain death","volume":"11","author":"Vanatta","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib66","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-6143.2006.01243.x","article-title":"Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN\/UNOS data","volume":"6","author":"Mateo","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MOT.0b013e328351083d","article-title":"Is extracorporeal hypothermic machine perfusion of the liver better than the \u2018good old icebox\u2019?","volume":"17","author":"Bae","year":"2012","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2013.11.023","article-title":"HOPE for human liver grafts obtained from donors after cardiac death","volume":"60","author":"Dutkowski","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib69","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1600-6143.2009.02680.x","article-title":"Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia\/reperfusion injury (IRI)","volume":"9","author":"Franchello","year":"2009","journal-title":"Am J Transplant"},{"issue":"RR-8","key":"10.1016\/j.cld.2016.12.004_bib70","first-page":"1","article-title":"Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention","volume":"43","year":"1994","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cld.2016.12.004_bib71","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1600-6143.2011.03518.x","article-title":"Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States","volume":"11","author":"Ellingson","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"key":"10.1016\/j.cld.2016.12.004_bib73","unstructured":"Centers for Disease Control and Prevention. Viral Hepatitis - Hepatitis C Information. Available at: http:\/\/www.cdc.gov\/hepatitis\/hcv\/. Accessed August, 25 2016."},{"key":"10.1016\/j.cld.2016.12.004_bib74","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","article-title":"Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis","volume":"23","author":"Northup","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.cld.2016.12.004_bib75","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00268-011-1019-5","article-title":"Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database","volume":"35","author":"Burr","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.cld.2016.12.004_bib76","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","article-title":"Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study","volume":"91","author":"Ballarin","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib77","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/lt.23396","article-title":"Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study","volume":"18","author":"Lai","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib78","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","article-title":"Liver grafts from anti-hepatitis B core positive donors: a systematic review","volume":"52","author":"Cholongitas","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib79","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/lt.22169","article-title":"Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis","volume":"16","author":"Cheung","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib80","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1111\/j.1399-0012.2011.01409.x","article-title":"Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis","volume":"25","author":"Skagen","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib81","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/lt.21788","article-title":"Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor","volume":"15","author":"Yu","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.004_bib82","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jhep.2012.11.025","article-title":"Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study","volume":"58","author":"Angelico","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib83","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1097\/00007890-200205270-00013","article-title":"Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis","volume":"73","author":"Joya-Vazquez","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.004_bib84","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/tri.12177","article-title":"Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors","volume":"26","author":"Choi","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.cld.2016.12.004_bib85","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2011.09.016","article-title":"Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool","volume":"56","author":"Loggi","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib86","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2014.05.003","article-title":"Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation","volume":"61","author":"Yu","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.004_bib87","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2016.12.004_bib88","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D: a:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2016.12.004_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.gastro.2009.09.053","article-title":"MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates","volume":"138","author":"Subramanian","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.004_bib90","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1600-6143.2012.04028.x","article-title":"Outcome of HCV\/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study","volume":"12","author":"Miro","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib91","doi-asserted-by":"crossref","first-page":"138","DOI":"10.7326\/M16-0560","article-title":"Realizing HOPE: the ethics of organ transplantation from HIV-positive donors","volume":"165","author":"Durand","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2016.12.004_bib92","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2011.03506.x","article-title":"Estimating the potential pool of HIV-infected deceased organ donors in the United States","volume":"11","author":"Boyarsky","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2016.12.004_bib93","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive-to-HIV-positive kidney transplantation\u2013results at 3 to 5 years","volume":"372","author":"Muller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.12.004_bib94","unstructured":"Department of Health and Human Services. Safeguards and research criteria for\u00a0transplantation of organs infected with HIV. Available at: https:\/\/www.niaid.nih.gov\/topics\/transplant\/research\/Documents\/HOPEactCriteria.pdf. Accessed August 28, 2016."}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611630112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932611630112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T12:59:33Z","timestamp":1719061173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932611630112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S108932611630112X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended Criteria Donors in Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}